Instil Bio, Inc. (TIL) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$78.58M | -6.9% |
| 2024 | -$73.54M | +53.8% |
| 2023 | -$159.17M | +29.7% |
| 2022 | -$226.46M | -45.6% |
| 2021 | -$155.56M | -362.4% |
| 2020 | -$33.64M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$78.58M | -6.9% |
| 2024 | -$73.54M | +53.8% |
| 2023 | -$159.17M | +29.7% |
| 2022 | -$226.46M | -45.6% |
| 2021 | -$155.56M | -362.4% |
| 2020 | -$33.64M | — |